The ALS Association of Georgia has received a $10,000 donation from William Mills Agency (WMA), an independent public relations and content marketing firm, to help the non-profit fund research and services to the local amyotrophic lateral sclerosis (ALS) community.
William Mills lost its founder, William ‘Bill’ Mills Jr., to ALS five years ago. He started the agency with his wife, Eloise, and worked closely with their two sons, William and Scott. He was an avid runner who participated in many fundraising events, including the Atlanta’s Peachtree Road Race more than 30 times.
William Mills began fundraising for the ALS Association in his memory. This year’s donation stems from its team of six runners who took part in for July 4 race, and also marked the agency’s 40th anniversary.
“We are extremely thankful to have such a generous, caring community of friends, partners and clients who joined us in helping make this donation possible,” Eloise Mills, chairman of William Mills Agency, said in a press release. “The outpouring of support for this campaign means a great deal to WMA. We hope our small donation will help in research toward the cause and cure for the disease. The donation in Bill’s memory makes it even more special.”
William Mays, based in Atlanta, specializes on content relating to the financial industry.
In related news, the ALS Association recently announced that it has established a disaster relief fund to help ALS patients and their families in parts of Texas and Louisiana affected by Hurricane Harvey.
The association’s Texas and Louisiana/Mississippi chapters are now trying to reach affected families and said that staging facilities have been provisionally set up in Houston to provide food, respiratory and other medical equipment, and personal care items to ALS patients there.
Anyone wishing to contribute to the disaster relief fund can do so at alsa.org/Harvey.
The donation was given to the research initiative Answer ALS, a joint research effort that involves six clinical sites, 24 research centers and about 1,000 patients, making it the largest ALS research initiative to date.